It's time we talked

Crucial Conversations are an essential but often missed part of breast cancer care. They are a moment that counts in a patient’s breast cancer journey, whether that’s between patients and their doctors or across the healthcare team. ‘Crucial Conversations’ might be an honest conversation with a breast cancer patient about issues with intimacy or menopause or a discussion about biomarker testing. It might also be ‘Crucial Conversations’ between HCPs about a particular patient’s care.

As part of our Moments that Count campaign, Novartis hosted a live virtual event intended to spark debate and discussion, shining a light on the importance of ‘crucial conversations’ in breast cancer care, and exploring what these look like as we move towards greater collaboration across the NHS system.

Doctor and Patient Talking

Panel Event Objectives

  • Creating ‘Crucial Conversations’ to improve patient care in breast cancer
  • Providing insights from a patient perspective on ‘Crucial Conversations’ with HCPs and the conversations that may be missed during care
  • Discussing the impact of ‘Crucial Conversations’ in the wider healthcare system   
  • Talking about the role of life sciences in facilitating 'Crucial Conversations'

Watch the virtual event highlights now

Moderator

The panel was moderated by Jacqui Thornton, award-winning health journalist and previous Health Editor of The Sun and health correspondent of The Sunday Telegraph.

Jaqui Picture

Panellists

We invited 5 panellists to share their experiences with ‘Crucial Conversations’ in breast cancer, including three patient advocates, a medical oncologist and Novartis UK’s Country President.

Marie-Andrée Gamache
Dr Ellen Copson
Lisa Fleming
Juliet FitzPatrick
Helena Boyce

Two additional MTC ambassadors watched the panel as live audience members and were given the opportunity to include their own perspectives on ‘Crucial Conversations’ in breast cancer.

Mary Huckle
Laura MIddleton-Hughes

Watch the full version

If you found this Crucial Conversation interesting, why not enjoy the full version now? There are plenty of additional interesting topics that didn't quite make the final cut, but you are sure to learn a lot from this insightful bunch.

 

 

UK | February 2023 | 262539

 

 

You know you best

Make your next appointment count

Your healthcare team is your best resource throughout your treatment. Talk openly and often with them about your doubts, questions and concerns. It might make you feel more in control if you take some time to plan for your appointment. Making notes before, during and after can help you retain information and make the most of your visits. We have developed a guide to support you in having these conversations with some tips to help you get the information you need.

Download your Moments That Count appointment guide.

Feedback
Moments That Count Logo

Terms of use | Cookies and Data Privacy | Cookie Settings

Moments That Count has been developed and funded by Novartis Pharmaceuticals UK Limited. It has been created in collaboration with secondary breast cancer patients whose knowledge and insights have informed the content and direction for the campaign.

This website is part of a programme that is funded by Novartis Pharmaceuticals UK Limited. Novartis Pharmaceuticals UK Limited is a private limited liability company registered in England and Wales under number 119006. Registered office 2nd Floor, The WestWorks Building, White City Place, 195 Wood Lane, London, W12 7FQ. Use of this website is governed by our Terms of Use and the Cookies and Privacy Policy.

Reporting side-effects

If you get side effects with any medication you are taking, talk to your doctor, pharmacist or nurse.This includes any possible side effects not listed in the information leaflet that comes in the pack. You can report side effects via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/. By reporting side effects, you can help provide more information on the safety of your medication.

©2022 Novartis Pharmaceuticals UK Ltd - UK | September 2022 | 124182-1 | This site is intended for an audience in the UK.